Command Palette

Search for a command to run...

Clinical Trials · NCT00003026

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Enrollment
966
Start date
Apr 1997
Locations
17 sites, 7 countries
Primary endpoint
Study in Prostate Cancer
View Gonadorelin compound reference